Mast Therapeutics masttherapeutics.com

Mast Therapeutics (NYSEMKT: MSTX), fka ADVENTRX Pharmaceuticals, is a biopharmaceutical company focused on in-licensing, developing, and commercializing proprietary product candidates primarily for the treatment of cancer. Mast's lead product candidate, AIR001, is a sodium nitrite solution for intermittent inhalation via nebulization in Phase 2 clinical development for the treatment of HFpEF.

Mast Therapeutics (NYSEMKT: MSTX), fka ADVENTRX Pharmaceuticals, is a biopharmaceutical company focused on in-licensing, developing, and commercializing proprietary product candidates primarily for the treatment of cancer. Mast's lead product candida...Show all

See All Exits Recent Exits

Phone: 858-552-0866

Fax:

3611 Valley Centre Drive
#500
San Diego, 92130
California, United States

Mast Therapeutics - Investments & Acquisitions

Show Real Data
See all Recent Investments
Date Company Round Amount Co-investors
2017-01-07SavaraReverse Merger
2014-02-27Aires PharmaceuticalsAcquired
See all 2 investments